Title: TOS DISNEA
1TOS- DISNEA
- Dr. Eduardo Gotuzzo
- Instituto de Medicina Tropical Alexander von
Humboldt - Universidad Peruana Cayetano Heredia
-
-
-
2Pneumocystis carinii pneumonia
- Between 1981-92 51 had PCP as their initial OI
- Prophylaxis era 28 of patients, 14.5 as
initial OI - (NEJM 19933291922-6)
- Increased risk CD4 lt 200 cells/mm3, oral thrush,
prolonged fevers - Mean CD4 79 (median 36) (Ann Intern Med
1996124633-42) - 10 of cases occur with CD4 gt 200 cells/mm3
- Symptoms
- Fever
- Slowly progressive dyspnea on exertion
- Nonproductive cough
3PCP in Patients in the Developing Countries
- During the first decade of the AIDS pandemic, PCP
rarely occurred in African adults - Tuberculosis and bacterial infection were more
common - More recent reports have noted that PCP comprises
a significantly greater percentage of cases of
pneumonia than it did in the past - Throughout the developing world, the rate of
coinfection with Mycobacterium tuberculosis and
PCP is high, ranging from 25 to 80
Clinical Infectious Diseases 2003 36708
4PCP Diagnosis
- Laboratory LDH in 82-100
- Non specific (disseminated histoplasmosis)
- Radiology
- Bilateral symmetric reticular infiltrates
- Less Common Focal or lobar infiltrates, nodules
with or without cavitation, pneumatoceles,
pneumothorax - Normal Chest X ray in 10 (0-39)
- Sputum
- Induced sputum
- BAL, TBB
5PCP Therapy
- High-dose cotrimoxazole (15-20 mg/kg/day of TMP)
for 21 days - Second choice
- IV pentamidine, 4 mg/kg per day for 21 days
- Alternatives
- Clindamycin and Primaquine
- Dapsone and Trimethoprim
- Atovaquone
- Trimetrexate (severe disease requiring IV
therapy) - Glucocorticoids if PaO lt 70mmHg
6HIV Pneumonia
- CAP more frequent than in general population
- TB important part of the differential because of
high rates of co-infection (30 in Africa) - PCP should be also suspected in newly diagnosed
persons and individuals not taking trim/sulfa
prophylaxis - CMV pneumonias, Cryptococcus also seen.
- Atypical Mycobacteria less common than in
industrial countries.
7HIV Pneumonia
- Etiologic diagnosis complicated by atypical
presentations and limited resources - Empirical therapy encouraged in limited resource
settings (CAP vs. TB vs. PCP). - WHO algorithm for managing respiratory tract
infection - Ampicillin or trim/sulfa
- TB therapy
- 32 cases of pneumonia failed to respond
Mwachari, C. et al JAIDS 2001 27365-71 - Infections can present simultaneously (PCPTB)
8HIV Pneumonia
- A significant cause of death in autopsy series
(Botswana) TB 45, bacterial pneumonia 23
Ansari, N. et al IJTLD 2002655-63 - Respiratory conditions accounted for 14.2 of HIV
hospital admissions in Botswana 1997 (TB,
bacterial pneumonia) Steen, T. et al IJTLD 2001
5775-82
9HIV Pneumonia
- Almenara Hospital, Lima, Peru (2000)
- TB 38/21317.8 hospitalizations,
- CAP purulent bronchitis, infected
bronchiectasis 12/2135.6 - Pulmonary disease continues to be an important
cause of hospitalization in patients receiving
HAART - 9/58 due to respiratory infections (15.5),
- 6 new diagnoses of TB in 45 patients
- Almenara Hospital, Lima, Peru, 2003
10HIV Pneumonia
- Bacterial pneumonia is common and occurs with a
similar prevalence in HIV-positive and
HIV-negative children hospitalized for pneumonia
Zar,H. Et al A Paediatr 2001 90119-25. - HIV-infected children have worse outcome. Case
fatality rates and bacterial susceptibility
patterns raise the issue of reevaluation of
empirical treatment of severe CAP Zar Madhi,S.
et al CID 200031170-6
1128 y.o. female, diagnosis of HIV in 10/01.
Admitted for 1 month cough, fever, weight loss.
Sputum for AFB positive. Current CD4 350.
1232 y.o. female, known HIV since 1999, past
history of TB and PCP, developed bronchiectasis.
Multiple admissions for purulent bronchitis.
Chronic respiratory insufficiency. Intolerance
to multiple HAART regimens. CD4 18
13CXR of a 26 yo patient with AIDS with proven
Cryptococcus infection depicts extensive right
hilar and mediastinal adenopathy and presence of
parahilar airspace consolidation. CD4 41.
14HIV-positive 25 y.o. male, originally from
Pucallpa. 6 month-history of fever and weight
loss, chronic cough, occasional hemoptysis and
left sided chest pain. Bronchoscopy positive for
both Histoplasma and M. tuberculosis
15Métodos
- Estudio observacional, prospectivo.
- Criterios de inclusión
- - Pacientes VIH/SIDA con sÃntomas respiratorios
por 7 dÃas o más o insuficiencia respiratoria. - - Consentimiento informado
- Criterios de exclusión
- - Diagnóstico clÃnico de infección respiratoria
alta - - Pacientes en tratamiento por episodio actual
de enfermedad respiratoria - Aprobado por el Comité Institucional de Etica
(UPCH) -
16Paciente es evaluado por Enfermera del estudio y
cumple criterios de inclusión /exclusión
PRIMER DIA
17 Recolección de 3 ml de esputo
SEGUNDO DIA
BACTERIOLOGIA -Cultivo en LJ -BK
directo -Concentración HSSH -Gram.
Toma de muestra de sangre 5cc
3CC INMUNOLOGIA -CD4 -Otros
1CC MICOLOGIA -SerologÃa
1CC SEROTECA -Backup
Llevar 2 láminas extendidas a MicologÃa -Giemsa -
O Toluidina
Toma de placa de Tórax
18TERCER DIA
Recolección de 3 ml de esputo
- MICOLOGIA
- -Cultivo para hongos
- -Inmunofluorescencia P.carinii
- -Giemsa 2
- -O Toluidina
- KOH
- Tinta China
Enviar el sobrante de muestra a Lab.
Microbiologia -BK directo
19Rutina de seguimiento
- Fecha de inclusión DIA 0º
- 1º Control DIA 3º
- 2º Control DIA 7º
- 3º Control DIA 14
- 4º Control DIA 28º
- 5º Control DIA 60º
- 6º Control DIA 90º
20Resultados preliminares
- Del 22 de Agosto del 2003 al 15 de Mayo del 2004.
- Número de pacientes incluidos 165
- Número de pacientes excluidos 53
21Recuento CD al ingreso
Recuento CD al ingreso
Percentiles 1
1 25 15
Observaciones 163 50 49
Media 111.98
DE 156.55 75 159
90 284
95 411 99
854 Â
22DIAGNOSTICOS
Diagnosticos
- PCP 86 (52.1)
- Sin Dx. Definitivo 25 (15.2)
- TBC 22 (13.3)
- Bronquitis 18 (10.9)
- PCP Y TBC 6 (3.6)
- Otros 8
(4.8) - TOTAL 165
23CausasCausas de fallecimiento
Causas de fallecimiento
- Insuficiencia respiratoria 8
- SIDA terminal 7
- Hipertensión endocraneana 1
- Anemia Aguda 1
- Falla multiorgánica 2
- TBC Multisistémica 1
- Pendiente revisión de historias 8
-
- Total 28
- Como se registra en la epicrisis
24Impacto de TBC y PCP en la mortalidad
- Fallecidos con PCP 10 (35.7)
- Fallecidos con TBC y PCP 5 (17.8)
- Fallecidos con TBC 7 (25.0)
- Fallecidos sin PCP/TBC 6 (21.4)
- TOTAL FALLECIDOS 28